Mobilisation kinetics of primitive haemopoietic cells following G-CSF with or without chemotherapy for advanced breast cancer

Annals of Oncology

Volumn 7, Issue 10, 1996, Pages 1051-1057

  Baumann, I ^a,b   Swindell, R ^a   Van Hoeff, M E H M ^a   Dexter, T M ^a   De Wynter, E ^a   Lange, C ^a   Luft, T ^a   Howell, A ^a   Testa, N G ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

advanced breast cancer; bone marrow stromal cultures; chemotherapy and G CSF; peripheral blood cell mobilisation

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BREAST CANCER; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030481290     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010498     Document Type: Article

References (39)

1. Elias AD, Ayash L, Andersen KC et al. Mobilization of peripheral blood progenitor cell by chemotherapy and granulocyte macrophage colony stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036-44.
2. Huan SD, Hester J, Spitzer G et al. Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and recombinant human granulocyte macrophage colony stimulating factor and high-dose cyclophosphamide, etoposide, and cisplatin. Blood 1992; 79: 3388-93.
3. Crown J, Kritz A, Vahdat L et al. Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer. J Clin Oncol 1993; 11: 1144-9.
4. Fields KK, Elfenbein GJ, Perkins JB et al. Two novel high-dose treatment regimens for metastatic breast cancer-ifosphamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: Outcomes and toxicities. Semin Oncol 1993; 20 (Suppl 6): 59-66.
5. To LB, Dyson PG, Branford AL et al. Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous hemopoietic reconstitution in acute non-lymphoblastic leukemia. Bone Marrow Transplant 1987; 2: 103-8.
6. Kessinger A, Armitage JO, Landmark JD et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988; 71: 723-7.
7. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-3.
8. To LB, Shepperd KM, Haylock DN et al. Single high-doses of cyclophosphamide enable the collection of high numbers of hematopoietic stem cells from the periphal blood. Exp Hematol 1990; 18: 442-7.
9. Pettengell R, Testa NG, Swindell R et al. Transplantation potential of haemopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 1993; 82: 2239-48.
10. Ravagnani F, Siena S, Bregni M et al. Large-scale collection of circulating haemopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur J Cancer 1990; 26: 562-4.
11. Peters WP, Rosner G, Ross M et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709-19.
12. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-4.
13. Henon PR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or stem cell transplantation. Bone Marrow Transplant 1992; 9: 285-91.
14. To LB, Roberts MM, Haylock DN et al. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-84.
15. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colony-stimulating factor 'mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993; 81: 2031-5.
16. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating haemopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-9.
17. Haas R, Möhle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autograftin of peripheral blood progenitor cells in malignant lymphomas. Blood 1994; 83: 3787-94.
18. Demuynck H, Pettengell R, de Campos E et al. The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow. Eur J Cancer 1992; 28: 381-6.
19. Sutherland HJ, Eaves CJ, Landsdorp PM et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808-14.
20. Pettengell R, Luft T, Henschler R et al. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 1994; 84: 3653-9.
21. Van Hoef MEHM, Baumann I, Lange C et al. Dose escalating induction chemotherapy supported by lenograstim proceeding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the optimal regiment induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for bone marrow rescue. Ann Oncol 1994; 5: 217-24.
22. Coutinho LH, Gilleece MH. de Wynter et al. Clonal and long-term cultures using human bone marrow. In Testa NG, Molinieux G (eds): Haemopoiesis: A Practical Approach. Oxford University Press 1993; 75-84.
23. Baumann I, Testa NG, Lange C et al. Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants. Lancet 1993; 341: 369.
24. Russell NH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341: 1482.
25. Weaver CH, Buckner CD, Longin K et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981-4.
26. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158-63.
27. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Haematol 1993; 21: 508-14.
28. Pettengell R, Morgenstern GR, Woll PJ et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993; 82: 3770-7.
29. Van Hoef MEHM, Ranson M, Morgenstern GR et al. Rapid haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cells (PBPC) as sole source of support collected at a single apheresis. Bone Marrow Transplant 1994; 13: 839-40.
30. Udomsakdi C, Lansdorp PM, Hogge DE et al. Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 1992; 80: 2513-21.
31. Weaver A, Ryder D, Dexter TM et al. Increasing numbers of LTCIC mobilized into the peripheral blood with increasing doses of stem cell factor in combination with filgastrim and chemotherapy. Twenty-fifth Meeting of the Soc of Exp Hematol. New York 1996 (Abstr 97).
32. Testa NG, Hendry JH, Molineux G. Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy. Anticancer Res 1985; 5: 101-10.
33. Molineux G, Xu Chengxiong, Hendry J, Testa NG. A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide. Cancer Chemother Pharmacol 1986; 18: 11-6.
34. Hornung RL, Longo DL. Haematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy. Blood 1992; 80: 77-83.
35. Fruehauf S, Haas R, Conradt C et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgastrim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood 1995; 85: 2619-26.
36. Bender JG, Unverzagt KL, Walker DE et al. Identification and comparison of CD34+ cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991 ; 77: 2591-6.
37. Kurihara N, Civin CI, Roodman GD. Multipotent haemopoietic colony forming cells are early precursors for osteoclasts. Exp Haematol 1988; 16(6): 473a.
38. Simmons PJ, Torok Storb B. Stromal cell precursors express the CD34+ antigen and the receptor or soybean agglutinin. Blood 1989; 74 (Suppl 1): 151a.
39. Gore SD, Kastan MB, Civin CI. Normal human bone marrow cells which express CD34+ and terminal deoxynucleotidyl transferase (TdT) include T-cells and putative lymphoid stem cells. Blood 1989; 74 (Suppl 1): 9a.